Cardinal Health, Inc.

Hello, and welcome to the third quarter fiscal year 2026 Cardinal Health Incorporated earnings conference call. My name is George, and I'll be the coordinator for today's event. Please note, this conference is being recorded, and for the duration of the call, you're going to be in the listen-only mode. However, you have the opportunity to ask questions towards the end of the presentation, and this can be done by pressing star 1 on your telephone keypad to register your questions. Also, can you please limit yourselves to one question each to allow the maximum attendees to ask a question? If you require assistance at any point, please press star zero and you will be connected to an operator. I'd like to have a call over to your host, Mr. Matt Sims, Vice President of Restoration, to begin today's conference. Please go ahead, sir.

Good morning. Good morning. And welcome to Cardinal Health's third quarter fiscal 26 earnings conference call, and thank you for joining us. With me today are Cardinal Health CEO Jason Holler and our CFO Aaron Ault. You can find this morning's earnings press release and investor presentation on the investor relations section of our website at ir.cardinalhealth.com. Since we will be making forward-looking statements today, let me remind you that the matters addressed in these statements are subject to risks and uncertainties that could cause our actual results to differ materially from those projected or implied. Please refer to our SEC filings and the forward-looking statement slide at the beginning of our presentation for a description of these risks and uncertainties. Please note that during our discussion today, the comments will be on a non-GAAP basis and less specifically called out as GAAP. GAAP to non-GAAP reconciliations for all relevant periods can be found in the supporting schedules attached to our press release. For the Q&A portion of today's call, we kindly ask that you limit questions to one per participant so that we can try and give everyone an opportunity. With that, I will now turn the call over to Jason.

Thanks, Matt, and good morning, everyone. We are pleased to report another strong quarter for Cardinal Health, building on the momentum we displayed over the past few years. This quarter's performance highlights the durability and resilience of our business and the team's disciplined execution. The results reinforce our conviction in the company's growth trajectory and ability to deliver long-term value creation. Our underlying operating strength continues to be led by our largest and most significant business, pharmaceutical and specialty solutions, and is amplified by contributions from our higher margin growth businesses. Within pharma, we delivered strong growth, highlighting the strength of our core. We continue to see benefits from our strategic focus on expanding our capabilities across specialty, both downstream with providers and upstream with manufacturers. We are progressing the expansion of our MSO platforms, in particular with the Specialty Alliance's multi-specialty offerings, delivering differentiated value to a growing network of physicians and enhancing patient care and access. The integration of Solaris into the Specialty Alliance remains on track, and we are taking actions to realize synergistic benefits across our portfolio. In GMPD, we continue to execute against our improvement plan. Our focus on simplification and cost optimization initiatives is producing tangible results and we continue to see notable strength in our portfolio of Cardinal Health brand products. Our deliberate actions to simplify operations, enhance supply chain resiliency, and drive commercial excellence remain strategic priorities as the business navigates the dynamic tariff environment. Our other growth businesses, At Home Solutions, Nuclear and Precision Health Solutions, and Optifreight Logistics continue to deliver robust results. Their sustained performance is a direct outcome of our continued strategic long-term investments in these areas, which are aligned with a favorable demand environment and positive secular trends in faster-growing areas of healthcare. The collective strength and sustained momentum across the enterprise, including our financial position, gives us the confidence to again raise our full-year outlook for fiscal 26 and highlight our expectations for continued momentum in fiscal 27. And with that, I'll turn it over to Aaron to review our financials and outlook.